Search

everythinglearnresearchcommunity

for

Search:↓

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

Skin problems are very common in people with end-stage kidney disease.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Both mouse and rat models are effective for testing alopecia areata treatments.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Fat cells are important for tissue repair and stem cell support in various body parts.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.